School of Medicine
Showing 1-9 of 9 Results
Natalie L. Rasgon
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult) and, by courtesy, of Obstetrics and Gynecology (Maternal Fetal Medicine) at the Stanford University Medical CenterOn Leave from 08/17/2020 To 02/11/2021
Current Research and Scholarly InterestsDr. Rasgon has been involved in longitudinal placebo-controlled neuroendocrine studies for nearly two decades, and she has been involved in neuroendocrine and brain imaging studies of estrogen effects on depressed menopausal women for the last eight years. It should be noted that in addition to her duties as a Professor of Psychiatry and Obstetrics & Gynecology, Dr. Rasgon is also the Director of the Behavioral Neuroendocrinology Program and of the Women's Wellness Program.
Matthew F. Reeves
Adjunct Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Matthew Reeves is the Executive Director and founder of the DuPont Clinic, a center providing patient-centered abortion care in all trimesters. With the team at the DuPont Clinic, Dr. Reeves has worked to re-envision the patient experience, create a new patient flow without a waiting room, develop new shortened protocols for later abortion, improve nurse-administered moderate sedation techniques, and introduce new and redesigned gynecologic instruments. Dr. Reeves also serves on the board of directors of DKT International, a social marketing organization that provided over 44 million couple-years of contraception in over 25 countries and is now the sole distributor for Ipas aspirators and Sino-Implant II. Previously, he was Medical Director of the National Abortion Federation where he worked to improve the quality of abortion care across North and South America. From 2010-2014, Dr. Reeves was the Chief Medical Officer of WomanCare Global where his work focused on expanding use of manual uterine aspiration and introducing mifepristone and levonorgestrel implants to new markets. Throughout his career, Dr. Reeves has worked on clinical research, primarily in the areas of post-abortal intrauterine contraception and improvements in abortion service delivery. In addition to this appointment at Stanford, he currently has an appointment as an Adjunct Associate Professor at the Johns Hopkins Bloomberg School of Public Health. Dr. Reeves attended Harvard Medical School and completed residency in obstetrics & gynecology at the University of California, San Francisco (UCSF). He then completed the fellowship in Clinical Ultrasound at UCSF followed by the Fellowship in Family Planning at the University of Pittsburgh.
Malte Renz, MD, PhD
Instructor, Obstetrics & Gynecology - Gynecologic Oncology
Current Research and Scholarly InterestsI am interested in cell motility and molecular dynamics. I believe that intra- and intercellular molecular dynamics, compartmentalization, and complex formation may differentiate disease from normal beyond the expression level of proteins and may constitute relevant pathomechanisms. The tools I am using are quantitative fluorescence live-cell microscopy on the ensemble and single-molecule level. I aim to bridge direct patient care and basic research.
Professor of Anesthesiology, Perioperative and Pain Medicine (OB) and, by courtesy, of Obstetrics and Gynecology at the Stanford University Medical CenterOn Partial Leave from 09/01/2020 To 02/12/2021
BioDr. Riley is a member of the Obstetric Anesthesia Division. He was the chief of the division for 12 years. His research interests focus on quality improvement and clinical questions relevant to obstetric anesthesia. He also has strong interest in international medicine. He is a board member and active clinician with the International Eye Institute and is active with Kybele (an international obstetric anesthesia outreach program),
Clinical Associate Professor, Obstetrics & Gynecology
Clinical Associate Professor (By courtesy), Urology
BioDr. Rogo-Gupta has a particular interest in a multi-disciplinary approach to women’s healthcare. Dr. Rogo-Gupta’s research interests include prolapse and incontinence surgery outcomes on both institutional and national levels, and the impact of surgical volume on outcomes.